Interview

'Keep developing your expertise'

Five questions with Anand Balakrishnan of Enanta Pharmaceuticals
Martina G. Efeyini
Sept. 16, 2022

Anand Balakrishnan talked to ASBMB Today about his work as principal scientist, specializing in biochemistry, at Enanta Pharmaceuticals Inc, a pharmaceutical company that focuses on antiviral drug discovery. Balakrishnan has been with the company for more than four years. This interview has been condensed and edited.

Anand Balakrishnan

Current position: Principal scientist at Enanta Pharmaceuticals

Education: Ph.D. in chemistry from Rutgers University and postdoctoral fellowship in microbiology and immunology at Weill Cornell Medicine 

First job outside of academia: Investigator II at Novartis Institutes for BioMedical Research

Favorite molecule or protein: "It’s actually this whole pathway of thiamine diphosphate biosynthesis, because it's very elegant chemistry and is important for all organisms."

What made you want to pursue an industry career?

During my postdoc work, I was working in infectious diseases — on Mycobacterium tuberculosis, which causes tuberculosis disease. A part of my project was working on drug discovery as there’s a lot of unmet medical need. I joined the infectious disease research group at Novartis, as I thought it was a good overlap of interest because my goal was to continue working in infectious diseases drug discovery.

What do you, as a principal scientist at Enanta, do?

I am a biochemist and enzymologist by training. I lead a biochemistry group supporting all the virology projects. For example, developing enzyme assays, doing biophysical studies, and structural biology. My group has been involved in studies on respiratory syncytial virus, SARS-CoV-2 and hepatitis B virus.

What does a typical day look like for you?

Usually my mornings are spent in meetings, mentoring group members or managing collaborations. I spend afternoons in the lab running experiments. We collaborate with biology and medicinal chemistry colleagues on a daily basis. As a biochemist, you get to learn a lot because you’re working across various diseases.

What are the top skills that have helped in your career?

I'm speaking as a drug-discovery biochemist. I think a strong understanding of the basics of chemistry and biology is important. Our role sometimes involves being translators between chemistry and biology, and we have to understand both languages. The ability to listen well to people, especially when you are part of a team where everybody is basically in a different field, is also needed.

My Ph.D. research was in enzymology. I gained in-depth expertise in the area and learned infectious disease drug discovery during my postdoc and in industry. So, from a career perspective, start in one area of science and keep developing your expertise. This your core strength. People will actually need you for that.

I think another important thing is realizing that biomedical research is really interconnected. So, while you develop your expertise in one area, keep an eye open to advances in other areas.

As you progress, I would say, writing, speaking and presentation skills also become important. You actually end up writing a lot, running project teams, and presenting data at internal and external meetings. So, whenever you get a chance, practice those skills.

What advice would you give someone who is interested in pursuing a similar career path? 

It depends on what stage the person is in. Planning is the most important career advice. Know where your passion is, and develop a plan to make a career in that field.

Next, I would say networking — trying to learn more about your chosen field and trying to connect with people to learn about their career paths. Start early when you are in graduate school or when you’re about to graduate to address questions about your next step. "Do I want to go into industry? Which field? What are the companies working in that field? Which company attracts me more?"

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Martina G. Efeyini

Martina G. Efeyini is a science communicator, STEM education advocate and former ASBMB Today careers columnist.

Featured jobs

from the ASBMB career center

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Careers

Careers highlights or most popular articles

Sketching, scribbling and scicomm
Science Communication

Sketching, scribbling and scicomm

April 16, 2025

Graduate student Ari Paiz describes how her love of science and art blend to make her an effective science communicator.

Embrace your neurodivergence and flourish in college
Diversity

Embrace your neurodivergence and flourish in college

April 14, 2025

This guide offers practical advice on setting yourself up for success — learn how to leverage campus resources, work with professors and embrace your strengths.

Upcoming opportunities
Announcement

Upcoming opportunities

April 9, 2025

Apply for the ASBMB Interactive Mentoring Activities for Grantsmanship Enhancement grant writing workshop by April 15.

Quieting the static: Building inclusive STEM classrooms
Interview

Quieting the static: Building inclusive STEM classrooms

April 8, 2025

Christin Monroe, an assistant professor of chemistry at Landmark College, offers practical tips to help educators make their classrooms more accessible to neurodivergent scientists.

Unraveling oncogenesis: What makes cancer tick?
ASBMB Annual Meeting

Unraveling oncogenesis: What makes cancer tick?

April 7, 2025

Learn about the ASBMB 2025 symposium on oncogenic hubs: chromatin regulatory and transcriptional complexes in cancer.

Exploring lipid metabolism: A journey through time and innovation
ASBMB Annual Meeting

Exploring lipid metabolism: A journey through time and innovation

April 4, 2025

Recent lipid metabolism research has unveiled critical insights into lipid–protein interactions, offering potential therapeutic targets for metabolic and neurodegenerative diseases. Check out the latest in lipid science at the ASBMB annual meeting.